AI Agents Modeled on Drug Companies Accelerate Drug Discovery

This announcement describes a virtual team of AI agents designed to mimic the structure of a traditional drug-development company. These AI agents collaborate by integrating biomedical and clinical evidence, aiming to make the drug discovery process more efficient and faster.

Originally published by gnews